108 related articles for article (PubMed ID: 17922276)
21. Multi-institutional phase II trial of S-1 in patients with oral squamous cell carcinoma.
Harada K; Sato M; Ueyama Y; Nagayama M; Hamakawa H; Nagahata S; Yoshimura Y; Osaki T; Ryoke K;
Anticancer Drugs; 2008 Jan; 19(1):85-90. PubMed ID: 18043133
[TBL] [Abstract][Full Text] [Related]
22. A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Morita S; Nakata B; Tsuji A; Mitachi Y; Shirasaka T; Saji S; Ohashi Y; Sakamoto J; Hirakawa K
Jpn J Clin Oncol; 2007 Dec; 37(12):924-9. PubMed ID: 18211983
[TBL] [Abstract][Full Text] [Related]
23. [Clinical study of TS-1 for inoperative and recurrent gastric cancer and evaluation of long survival cases].
Tanabe K; Yoshida K; Hamai Y; Ukon K; Ohta K; Hihara J; Toge T
Gan To Kagaku Ryoho; 2005 Aug; 32(8):1145-8. PubMed ID: 16121917
[TBL] [Abstract][Full Text] [Related]
24. [Problems of adjuvant chemotherapy with S-1 for gastric cancer].
Teshima S; Saito T; Endo A; Yunome G; Harada A; Ooshio H; Kodama H; Takeda K; Kikuchi S
Gan To Kagaku Ryoho; 2010 Feb; 37(2):255-8. PubMed ID: 20154480
[TBL] [Abstract][Full Text] [Related]
25. [Pilot study of neo-adjuvant chemotherapy involving intraperitoneal administration of paclitaxel and oral S-1 for patients with T3 gastric cancer].
Tamura S; Miki H; Okada K; Yoshimura M; Uji K; Yoshida A; Suzuki R; Nakahira S; Egawa C; Nakata K; Okamura S; Sugimoto K; Takatsuka Y
Gan To Kagaku Ryoho; 2008 Nov; 35(12):2024-6. PubMed ID: 19106511
[TBL] [Abstract][Full Text] [Related]
26. [The efficacy of S-1 monotherapy as a 2nd/3rd-line therapy for unresectable recurrent colon cancer: Kanagawa conference of clinical oncology (KCCO)].
Yokoyama T; Tokuhara H; Egawa T; Hashimoto O; Seki H; Koyanagi K; Bessho T
Gan To Kagaku Ryoho; 2009 Oct; 36(10):1667-70. PubMed ID: 19838025
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer.
Narahara H; Fujitani K; Takiuchi H; Sugimoto N; Inoue K; Uedo N; Tsukuma H; Tsujinaka T; Furukawa H; Taguchi T
Oncology; 2008; 74(1-2):37-41. PubMed ID: 18544958
[TBL] [Abstract][Full Text] [Related]
28. Predictive value of chemotherapy-induced neutropenia for the efficacy of oral fluoropyrimidine S-1 in advanced gastric carcinoma.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Br J Cancer; 2007 Jul; 97(1):37-42. PubMed ID: 17551497
[TBL] [Abstract][Full Text] [Related]
29. Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer.
Yamanaka T; Matsumoto S; Teramukai S; Ishiwata R; Nagai Y; Fukushima M
Gastric Cancer; 2007; 10(2):129-34. PubMed ID: 17577624
[TBL] [Abstract][Full Text] [Related]
30. [S-1 monotherapy for pancreatic cancer].
Okusaka T; Ueno H; Ikeda M; Morizane C
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():207-12. PubMed ID: 16898004
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology.
Ako E; Ohira M; Yamashita Y; Kubo N; Muguruma K; Yashiro M; Sawada T; Nakata B; Kato Y; Hirakawa K
Hepatogastroenterology; 2008; 55(86-87):1939-42. PubMed ID: 19102427
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of the sequential administration of S-1 and cisplatin for metastatic gastric cancer.
Baba E; Fujishima H; Kusaba H; Esaki T; Ariyama H; Kato K; Tanaka R; Mitsugi K; Shibata Y; Harada M; Nakano S
Anticancer Res; 2009 May; 29(5):1727-32. PubMed ID: 19443394
[TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Choi YJ; Chung JS; Shin HJ; Cho GJ; Wang SG; Lee BJ; Cho BM; Joo YD; Sohn CH
J Laryngol Otol; 2008 Aug; 122(8):848-53. PubMed ID: 18047761
[TBL] [Abstract][Full Text] [Related]
34. A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
Chen JS; Rau KM; Chen YY; Huang JS; Yang TS; Lin YC; Liau CT; Lee KD; Su YC; Kao RH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):819-25. PubMed ID: 18663448
[TBL] [Abstract][Full Text] [Related]
35. Phase II study of combination chemotherapy with S-1 and weekly cisplatin in patients with previously untreated advanced non-small cell lung cancer.
Ozawa Y; Inui N; Naitoh T; Yasuda K; Nagayama M; Shirai T; Suganuma H; Fujii M; Nakamura H; Suda T; Chida K
Lung Cancer; 2009 Jan; 63(1):68-71. PubMed ID: 18513824
[TBL] [Abstract][Full Text] [Related]
36. [Feasibility of S-1/CDDP therapy for outpatients with advanced gastric cancer].
Rino Y; Murakami H; Yukawa N; Wada N; Oshima T; Matsuura H; Sugano N; Arai H; Masuda M; Imada T
Gan To Kagaku Ryoho; 2009 Nov; 36(11):1829-31. PubMed ID: 19920383
[TBL] [Abstract][Full Text] [Related]
37. Phase I/II study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer.
Kawabata R; Fujiwara Y; Doki Y; Fujita J; Tsukahara Y; Yamasaki M; Miyata H; Takiguchi S; Monden M
Oncology; 2007; 72(3-4):219-25. PubMed ID: 18176087
[TBL] [Abstract][Full Text] [Related]
38. [Case report of gastric cancer patient who suffered life-threatening adverse events including severe myelosuppression during neoadjuvant chemotherapy with S-1 and CDDP combination].
Ueda S; Yoshida M; Hashida H; Tada M; Takabayashi A; Kanai M
Gan To Kagaku Ryoho; 2008 Sep; 35(9):1577-81. PubMed ID: 18799915
[TBL] [Abstract][Full Text] [Related]
39. Second-line chemotherapy with biweekly paclitaxel after failure of fluoropyrimidine-based treatment in patients with advanced or recurrent gastric cancer: a report from the gastrointestinal oncology group of the Tokyo cooperative oncology group, TCOG GC-0501 trial.
Koizumi W; Akiya T; Sato A; Yamaguchi K; Sakuyama T; Nakayama N; Tanabe S; Higuchi K; Sasaki T; Sekikawa T;
Jpn J Clin Oncol; 2009 Nov; 39(11):713-9. PubMed ID: 19812061
[TBL] [Abstract][Full Text] [Related]
40. A study of weekly paclitaxel plus 5-fluorouracil and cisplatin for patients with advanced or recurrent inoperable gastric cancer.
Gu Y; Shu Y; Xu Q
Biomed Pharmacother; 2009 May; 63(4):293-6. PubMed ID: 18848761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]